{
    "clinical_study": {
        "@rank": "130969", 
        "arm_group": [
            {
                "arm_group_label": "Inspiratory muscle training", 
                "arm_group_type": "Experimental", 
                "description": "Inspiratory muscle training for improving maximum inspiratory pressure plus phrmacological treatment Pharmacological treatment (usual care)"
            }, 
            {
                "arm_group_label": "Usual care", 
                "arm_group_type": "Active Comparator", 
                "description": "Pharmacological treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "Previous studies have evaluated the effects of inspiratory muscle training in patiens with\n      heart failure and reduced ejection fraction; nevertheless,no evidence endorse the\n      therapeutic role of inspiratory muscle training in patients with heart failure and preserved\n      ejection fraction. The investigators sought to evaluate whether 12-week inspiratory muscle\n      training improves exercise capacity (peak exercise oxygen uptake and 6-minutes walk test),\n      as well as left ventricular diastolic function, serum biomarkers and quality of life\n      (Minnesota Living With Heart Failure Questionnaire) in patients with heart failure with\n      preserved ejection fraction and non-reduced inspiratory muscle strength."
        }, 
        "brief_title": "The Effects of Inspiratory Muscle Training in Patients With Heart Failure With Preserved Ejection Fraction", 
        "completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Aspiration", 
                "Heart Failure"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  a) previous history of symptomatic heart failure (New York Heart Association [NYHA]\n             functional class \u2265II)\n\n          -  b) evidence of normal left ventricular ejection fraction, defined by an ejection\n             fraction >0.50 and an end-diastolic diameter <60 mm by 2D echocardiography\n\n          -  c) relevant structural heart disease (left ventricle hypertrophy/left atrial\n             enlargement) and/or diastolic dysfunction estimated by 2D echocardiography\n\n          -  d) clinical stability, including no admissions in the past 30 days\n\n        Exclusion Criteria:\n\n          -  a) Patients unable to perform a valid baseline exercise test.\n\n          -  b) Unstable angina, myocardial infarction or cardiac surgery within the previous\n             three months.\n\n          -  c)Known chronic metabolic, orthopedic, infectious disease or previous pulmonary\n             disease;\n\n          -  d)Treatment with steroids, hormones, or cancer chemotherapy;\n\n          -  e)Reduced maximal inspiratory pressure according to age and sex;\n\n          -  f)Active smokers\n\n          -  g)Acute decompensation;\n\n          -  h)Other comorbidity with an expectancy of life less than one year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "26", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 9, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01707277", 
            "org_study_id": "EMI"
        }, 
        "intervention": [
            {
                "arm_group_label": "Inspiratory muscle training", 
                "description": "Patients were instructed to train at home twice daily for 20 minutes each session during 12 weeks with a threshold inspiratory muscle trainer (Threshold IMT\u00ae, Respironics Inc.). All of them were trained under the supervision of a physiotherapist and educated to maintain diaphragmatic breathing during training. The subjects started breathing at a resistance equal to 25-30% of their maximum inspiratory pressure for 1 week.", 
                "intervention_name": "Inspiratory muscle training", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Inspiratory muscle training", 
                    "Usual care"
                ], 
                "description": "Usual pahramacological treatment", 
                "intervention_name": "Usual care", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Heart failure with preserved ejection fraction", 
            "Inspiratory muscle training", 
            "Exercise capacity"
        ], 
        "lastchanged_date": "October 12, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Valencia", 
                    "country": "Spain", 
                    "zip": "46010"
                }, 
                "name": "Hospital Cl\u00ednico Universitario"
            }
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effects of Inspiratory Muscle Training in Patients With Heart Failure With Preserved Ejection Fraction", 
        "overall_official": {
            "affiliation": "University of Valencia", 
            "last_name": "Julio N\u00fa\u00f1ez, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Exercise parameters: peak exercise oxygen uptake (peak VO2), 6-minutes walk test", 
            "measure": "Changes in exercise capacity parameters at 12-weeks.", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "reference": {
            "PMID": "22993500", 
            "citation": "Lin SJ, McElfresh J, Hall B, Bloom R, Farrell K. Inspiratory muscle training in patients with heart failure: a systematic review. Cardiopulm Phys Ther J. 2012 Sep;23(3):29-36."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01707277"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Valencia", 
            "investigator_full_name": "Julio N\u00fa\u00f1ez,MD", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Quality of life: Minnesota Living With Heart Failure Questionnaire. Biomarkers: plasma natriuretic peptides, estimaated glomerular filtration rate, antigen carbohydrate 125.\nDiastolic function: E/e\u00b4.", 
            "measure": "Changes in 12-week quality of life,  biomarkers related to the severity and parameters of left ventricular diastolic function.", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "University of Valencia", 
        "sponsors": {
            "collaborator": {
                "agency": "Fundaci\u00f3n para la Investigaci\u00f3n del Hospital Cl\u00ednico de Valencia", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Valencia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}